CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Novo Nordisk A/S v. Hims & Hers Health, Inc.

1:26-cv-00143

Overview

Case Number 1:26-cv-00143
Filing Date 2026-02-09
Status Terminated
Termination Date 2026-03-09
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

Hims, Inc. Operating Company

Represented By

1 Attorneys Listed

Andrew Colin Mayo

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Hims & Hers Health, Inc. Operating Company

Represented By

1 Attorneys Listed

Andrew Colin Mayo

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Plaintiff

Novo Nordisk Inc. Operating Company

Represented By

2 Attorneys Listed

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Rodger Dallery Smith , II

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9205

1201 North Market Street, P.O. Box 1347

Novo Nordisk A/S NPE (Individual / Inventor)

Represented By

2 Attorneys Listed

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Rodger Dallery Smith , II

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9205

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 1 proceeding
πŸ›οΈ
USPTO PTAB Trials 2 proceedings
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): πŸ‡ͺπŸ‡Ί Europe πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (3 found):
PTAB: 2 U.S. Courts: 1
USPTO PTAB Trial 2023-03-16
IPR2023-00723

Mylan Pharmaceuticals Inc. et al. v. Novo Nordisk A/S

Asserted Patent
Status: Institution Denied
USPTO PTAB Trial 2023-03-16
IPR2023-00722

Mylan Pharmaceuticals Inc. et al. v. Novo Nordisk A/S

U.S. Continuation Sibling (8536122)
Status: Institution Denied
U.S. District Court 2023-01-27
1:23-cv-00013

Novo Nordisk, Inc. v. Viatris Inc.

Asserted Patent
Status: WVND
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8129343
Acylated GLP-1 compounds
Filed: 2006-03-20
Issued: 2012-03-06
Active (4.0 yrs remaining) +1722d PTA
Expires: 2030-12-06

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+1722 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

2

Dispositive

0

Granted

0

Denied

0

Pending / Review

1

Motions by Category

Procedural / Extension Motion 2

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
Joint STIPULATION TO EXTEND TIME for Defendants to move, answer, or otherwise respond to the Complaint to April 1, 2026 - filed by Hims & Hers Health, Inc., Him...
Entry #9 • 2026-02-26 Document →
Procedural / Extension Motion Pending
SO ORDERED, re 9 Joint STIPULATION TO EXTEND TIME for Defendants to move, answer, or otherwise respond to the Complaint to April 1, 2026, filed by Hims & Hers H...
Entry #β€” • 2026-02-26

Docket Entries

(23 total)
Pleading / Complaint

COMPLAINT with Jury Demand against Hims & Hers Health, Inc., Hims, Inc. (Filing fee $ 405, receipt number ADEDC-4895718) - filed by Novo Nordisk Inc., Novo Nordisk A/S. (Attachments: # 1 Exhibits 1-6, # 2 Civil Cover Sheet)(scs) (Entered: 02/09/2026)

Entry #1 • 2026-02-09
1
Pleading / Complaint

COMPLAINT with Jury Demand against Hims & Hers Health, Inc., Hims, Inc. (Filing fee $ 405, receipt number ADEDC-4895718) - filed by Novo Nordisk Inc., Novo Nordisk A/S. (Attachments: # 1 Exhibits 1-6, # 2 Civil Cover Sheet)(scs) (Entered: 02/09/2026)

Entry #1 • 2026-02-09
2
Pleading / Complaint

COMPLAINT with Jury Demand against Hims & Hers Health, Inc., Hims, Inc. (Filing fee $ 405, receipt number ADEDC-4895718) - filed by Novo Nordisk Inc., Novo Nordisk A/S. (Attachments: # 1 Exhibits 1-6, # 2 Civil Cover Sheet)(scs) (Entered: 02/09/2026)

Entry #1 • 2026-02-09
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (scs) (Entered: 02/09/2026)

Entry #2 • 2026-02-09
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,129,343 B2. (scs) (Entered: 02/09/2026)

Entry #3 • 2026-02-09
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc